Future Health ESG Profit Margin 2022-2023 | FHLT
Current and historical gross margin, operating margin and net profit margin for Future Health ESG (FHLT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Future Health ESG net profit margin as of December 31, 2023 is 0%.
| Future Health ESG Annual Profit Margins |
|---|
| Future Health ESG Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Future Health ESG Corp. entered into a definitive business combination agreement with Excelera DCE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.557B | 53.26 |
| Tempus AI (TEM) | United States | $9.312B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.304B | 97.39 |
| Inspire Medical Systems (INSP) | United States | $4.724B | 73.15 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Privia Health (PRVA) | United States | $2.788B | 208.91 |
| Enovis (ENOV) | United States | $1.951B | 12.07 |
| Schrodinger (SDGR) | United States | $1.898B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.483B | 0.00 |
| Omnicell (OMCL) | United States | $1.428B | 30.80 |
| Azenta (AZTA) | United States | $1.197B | 55.74 |
| 10x Genomics (TXG) | United States | $1.053B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.539B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 313.00 |
| Veradigm (MDRX) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.393B | 0.00 |
| Claritev (CTEV) | United States | $0.346B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.221B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| Pulmonx (LUNG) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.083B | 0.00 |
| CareCloud (CCLD) | United States | $0.074B | 3.18 |
| 111 (YI) | China | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |